Efficacy of Simvastatin in Bone Regeneration After Surgical Removal of Mandibular Third Molars: A Clinical Pilot Study
- PMID: 26225047
- PMCID: PMC4510091
- DOI: 10.1007/s12663-014-0697-6
Efficacy of Simvastatin in Bone Regeneration After Surgical Removal of Mandibular Third Molars: A Clinical Pilot Study
Abstract
Introduction: Simvastatin, a common cholesterol-lowering drug that inhibits hepatic hydroxymethylglutaryl coenzyme A reductase, the rate-limiting enzyme in the mevalonate pathway, increases expression of the BMP-2 gene and thus promotes bone regeneration.
Materials and methods: A study was conducted in mandibular third molar sockets to study the efficacy of the drug by implanting it into sockets (experimental group) and observations were made over 3 months to compare the healing with the (control group).
Conclusion: The results showed faster regeneration of the bone in the simvastatin site using the gray level histogram values.
Keywords: Bone regeneration; Simvastatin; Third molar sockets.
Figures
References
-
- Wong RWK, Rabie ABM. Statin-induced osteogenesis uses in orthodontics: a scientific review. World J Orthod. 2006;7:35–40. - PubMed
-
- Mouhamed ALM, Ismail Mouhamed A, Sadek H. Evaluation of the outcome of adding biological modifier (simvastatin) to bone grafting material. Int J Oral Maxillofac Surg. 2009;38(5):455. doi: 10.1016/j.ijom.2009.03.210. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources